Valuation Kobayashi Pharmaceutical Co., Ltd.

Stocks

4967

JP3301100008

Personal Products

Delayed 02:30:00 2026-09-24 EDT 5-day change 1st Jan Change
5,885.00 JPY +0.43% Intraday chart for Kobayashi Pharmaceutical Co., Ltd. +1.52% +8.42%

Company Valuation: Kobayashi Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 704,427 650,295 503,841 463,131 403,511 437,483 - -
Change - -7.68% -22.52% -8.08% -12.87% 8.42% - -
Enterprise Value (EV) 1 596,011 546,554 424,992 398,232 333,575 375,070 367,459 361,687
Change - -8.3% -22.24% -6.3% -16.24% 12.44% -2.03% -1.57%
P/E 35.8x 34.8x 25.3x 46x 110x 42.3x 32.5x 26.3x
PBR 3.59x 3.47x 2.47x 2.18x 1.92x 2.09x 2.02x 1.96x
PEG - 12.08x 7.7x -0.9x -1.7x 0x 1.1x 1.1x
Capitalization / Revenue 4.54x 3.91x 2.9x 2.8x 2.43x 2.54x 2.44x 2.35x
EV / Revenue 3.84x 3.29x 2.45x 2.4x 2.01x 2.18x 2.05x 1.94x
EV / EBITDA 19.3x 17.1x 13.3x 12.1x 14.1x 17x 13.7x 11.6x
EV / EBIT 22.9x 20.5x 16.5x 16x 22.4x 29.3x 21.2x 17x
EV / FCF 31.8x 31.1x -350x -29.2x 68.5x 26.1x 24.1x 21.1x
FCF Yield 3.15% 3.22% -0.29% -3.42% 1.46% 3.83% 4.14% 4.73%
Dividend per Share 2 83 90 101 102 104 106 109.5 114.3
Rate of return 0.92% 1% 1.49% 1.64% 1.92% 1.8% 1.86% 1.94%
EPS 2 252.4 259.6 268.2 135.4 49.19 139.1 181.1 223.7
Distribution rate 32.9% 34.7% 37.7% 75.3% 211% 76.2% 60.5% 51.1%
Net sales 1 155,252 166,258 173,455 165,600 165,742 172,061 179,446 186,503
EBITDA 1 30,900 32,027 31,837 32,800 23,600 22,012 26,890 31,112
EBIT 1 26,065 26,669 25,780 24,860 14,923 12,780 17,350 21,293
Net income 1 19,715 20,022 20,338 10,067 3,656 10,438 13,554 16,348
Net Debt 1 -108,416 -103,741 -78,849 -64,899 -69,936 -62,413 -70,024 -75,796
Reference price 2 9,040.00 9,030.00 6,790.00 6,230.00 5,428.00 5,885.00 5,885.00 5,885.00
Nbr of stocks (in thousands) 77,923 72,015 74,203 74,339 74,339 74,339 - -
Announcement Date 2/4/22 2/14/23 2/9/24 2/10/25 2/10/26 - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
42.12x2.17x16.95x1.81% 2.75B
21.65x4.13x15.12x2.98% 342B
18.4x2.73x12.04x3.51% 134B
23.37x3.52x14.77x2.47% 68.5B
40.59x6.52x28.27x2.31% 47.83B
33.33x2.62x14.55x1.62% 35.76B
18.61x2.63x10.97x4.78% 33.94B
22.5x1.64x10.48x2.25% 19.87B
20.02x1.28x8.36x1.31% 18.86B
15.26x1.47x8.29x3.49% 17.97B
Average 25.58x 2.87x 13.98x 2.65% 72.13B
Weighted average by Cap. 22.80x 3.61x 14.70x 2.95%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 4967 Stock
  4. Valuation Kobayashi Pharmaceutical Co., Ltd.